These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 11280802)

  • 1. EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
    Zelinski DP; Zantek ND; Stewart JC; Irizarry AR; Kinch MS
    Cancer Res; 2001 Mar; 61(5):2301-6. PubMed ID: 11280802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.
    Carles-Kinch K; Kilpatrick KE; Stewart JC; Kinch MS
    Cancer Res; 2002 May; 62(10):2840-7. PubMed ID: 12019162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential EphA2 epitope display on normal versus malignant cells.
    Coffman KT; Hu M; Carles-Kinch K; Tice D; Donacki N; Munyon K; Kifle G; Woods R; Langermann S; Kiener PA; Kinch MS
    Cancer Res; 2003 Nov; 63(22):7907-12. PubMed ID: 14633720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
    Lu M; Miller KD; Gokmen-Polar Y; Jeng MH; Kinch MS
    Cancer Res; 2003 Jun; 63(12):3425-9. PubMed ID: 12810680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase.
    Zelinski DP; Zantek ND; Walker-Daniels J; Peters MA; Taparowsky EJ; Kinch MS
    J Cell Biochem; 2002; 85(4):714-20. PubMed ID: 11968011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
    van Golen KL; Wu ZF; Qiao XT; Bao LW; Merajver SD
    Cancer Res; 2000 Oct; 60(20):5832-8. PubMed ID: 11059780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
    Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
    Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.
    Noblitt LW; Bangari DS; Shukla S; Knapp DW; Mohammed S; Kinch MS; Mittal SK
    Cancer Gene Ther; 2004 Nov; 11(11):757-66. PubMed ID: 15359289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
    Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
    Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis.
    Nakamoto M; Bergemann AD
    Microsc Res Tech; 2002 Oct; 59(1):58-67. PubMed ID: 12242697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immortalized mammary epithelial cells overexpressing protein kinase C gamma acquire a malignant phenotype and become tumorigenic in vivo.
    Mazzoni E; Adam A; Bal de Kier Joffe E; Aguirre-Ghiso JA
    Mol Cancer Res; 2003 Aug; 1(10):776-87. PubMed ID: 12939403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.
    Zantek ND; Azimi M; Fedor-Chaiken M; Wang B; Brackenbury R; Kinch MS
    Cell Growth Differ; 1999 Sep; 10(9):629-38. PubMed ID: 10511313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species.
    Park SA; Na HK; Kim EH; Cha YN; Surh YJ
    Cancer Res; 2009 Mar; 69(6):2416-24. PubMed ID: 19276383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
    Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
    Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.
    Fang WB; Brantley-Sieders DM; Parker MA; Reith AD; Chen J
    Oncogene; 2005 Nov; 24(53):7859-68. PubMed ID: 16103880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy.
    Noblitt LW; Bangari DS; Shukla S; Mohammed S; Mittal SK
    Cancer Gene Ther; 2005 Jan; 12(1):46-53. PubMed ID: 15486559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand binding up-regulates EphA2 messenger RNA through the mitogen-activated protein/extracellular signal-regulated kinase pathway.
    Pratt RL; Kinch MS
    Mol Cancer Res; 2003 Dec; 1(14):1070-6. PubMed ID: 14707290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells.
    Zhang HT; Zhang X; Zhao HZ; Kajino Y; Weber BL; Davis JG; Wang Q; O'Rourke DM; Zhang HB; Kajino K; Greene MI
    Oncogene; 1997 Jun; 14(24):2863-9. PubMed ID: 9205094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.
    Hui AY; Meens JA; Schick C; Organ SL; Qiao H; Tremblay EA; Schaeffer E; Uniyal S; Chan BM; Elliott BE
    J Cell Biochem; 2009 Aug; 107(6):1168-81. PubMed ID: 19533669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
    Liu DP; Wang Y; Koeffler HP; Xie D
    Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.